Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 71 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 6258870

    Gels for encapsulation of biological materials

    The Board of Regents of the University of Texas System · Granted Jul 10, 2001 · Expires Jul 5, 2021

    expired

  2. US 6251878

    Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotective tamarind oligosaccharides

    The Board of Regents of the University of Texas System · Granted Jun 26, 2001 · Expires Jun 21, 2021

    expired

  3. US 6251871

    P16 expression constructs and their application in cancer therapy

    The Board of Regents of the University of Texas System · Granted Jun 26, 2001 · Expires Jun 21, 2021

    expired

  4. US 6248351

    Human PEA3 is a tumor suppressor for cancer cells

    The Board of Regents of the University of Texas System · Granted Jun 19, 2001 · Expires Jun 14, 2021

    expired

  5. US 6242418

    Therapeutic uses of BPI protein products for human meningococcemia

    The Board of Regents of the University of Texas System · Granted Jun 5, 2001 · Expires May 31, 2021

    expired

  6. US 6231892

    Compositions for coating microcapsules and other surfaces

    The Board of Regents of the University of Texas System · Granted May 15, 2001 · Expires May 10, 2021

    expired

  7. US 6210873

    Methods and compositions for the priming of specific cytotoxic T-lymphocyte response

    The Board of Regents of the University of Texas System · Granted Apr 3, 2001 · Expires Mar 29, 2021

    expired

  8. US 6207690

    Troglitazone compounds for treating climacteric and cancer

    The Board of Regents of the University of Texas System · Granted Mar 27, 2001 · Expires Mar 22, 2021

    expired

  9. US 6203793

    Compositions and methods for treating thermal injury

    The Board of Regents of the University of Texas System · Granted Mar 20, 2001 · Expires Mar 15, 2021

    expired

  10. US 6201165

    Transgenic animal models for cardiac hypertrophy and methods of use thereof

    The Board of Regents of the University of Texas System · Granted Mar 13, 2001 · Expires Mar 8, 2021

    expired

  11. US 6200597

    Formulation and use of carotenoids in treatment of cancer

    The Board of Regents of the University of Texas System · Granted Mar 13, 2001 · Expires Mar 8, 2021

    expired

  12. US 6197754

    Suppression of tumor growth by a mini-E1A gene

    The Board of Regents of the University of Texas System · Granted Mar 6, 2001 · Expires Mar 1, 2021

    expired

  13. US 6194176

    Recombinant expression of proteins from secretory cell lines

    The Board of Regents of the University of Texas System · Granted Feb 27, 2001 · Expires Feb 22, 2021

    expired

  14. US 6194481

    Mechanically strong and transparent or translucent composites made using zirconium oxide nanoparticles

    The Board of Regents of the University of Texas System · Granted Feb 27, 2001 · Expires Feb 22, 2021

    expired

  15. US 6184224

    Antitumor dibenzofluorene derivatives

    The Board of Regents of the University of Texas System · Granted Feb 6, 2001 · Expires Feb 1, 2021

    expired

  16. US 6184254

    Methods of identifying modulators of perivascular sensory nerve Ca2+ receptors

    The Board of Regents of the University of Texas System · Granted Feb 6, 2001 · Expires Feb 1, 2021

    expired

  17. US 6172212

    Pea3 is a tumor suppressor

    The Board of Regents of the University of Texas System · Granted Jan 9, 2001 · Expires Jan 4, 2021

    expired

  18. US 6171856

    Methods and compositions relating to no-mediated cytotoxicity

    The Board of Regents of the University of Texas System · Granted Jan 9, 2001 · Expires Jan 4, 2021

    expired

  19. US 6165461

    Tao protein kinases and methods of use therefor

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  20. US 6165440

    Radiation and nanoparticles for enhancement of drug delivery in solid tumors

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  21. US 6166079

    DFMO for the treatment or prevention of cervical intraepithelial neoplasia

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  22. US 6165484

    EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  23. US 6165745

    Recombinant production of immunoglobulin-like domains in prokaryotic cells

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

  24. US 6165990

    Antisense polynucleotide

    The Board of Regents of the University of Texas System · Granted Dec 26, 2000 · Expires Dec 21, 2020

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.